Skip to content
Business Segments · Research and development expenses

Specialty Diagnostics — Research and development expenses

Thermo Fisher Scientific Specialty Diagnostics — Research and development expenses remained flat by 0.0% to $44M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.2%, from $45M to $44M.

Analysis

StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityStable
First reportedQ1 2023
Last reportedQ1 2026May 1, 2026
Rolls up toR&D

How to read this metric

Increased investment suggests a focus on long-term innovation, while decreased investment may signal a shift toward cost-cutting or a mature product cycle.

Detailed definition

Expenditures dedicated to the discovery, development, and improvement of new diagnostic technologies, reagents, and clin...

Peer comparison

Critical metric for evaluating competitive positioning in the highly innovative diagnostic market.

Metric ID: tmo_segment_specialty_diagnostics_research_and_development_expenses

Historical Data

11 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$39M$39M$39M$39M$44M$48M$45M$47M$42M$44M$44M
QoQ Change+0.0%+0.0%+0.0%+12.8%+9.1%-6.3%+4.4%-10.6%+4.8%+0.0%
YoY Change+12.8%+23.1%-4.5%-8.3%-2.2%
Range$39M$48M
CAGR+4.9%
Avg YoY Growth+4.2%
Median YoY Growth-2.2%
Current Streak2 quarters growth

Frequently Asked Questions

What is Thermo Fisher Scientific's specialty diagnostics — research and development expenses?
Thermo Fisher Scientific (TMO) reported specialty diagnostics — research and development expenses of $44M in Q1 2026.
How has Thermo Fisher Scientific's specialty diagnostics — research and development expenses changed year-over-year?
Thermo Fisher Scientific's specialty diagnostics — research and development expenses decreased by 2.2% year-over-year, from $45M to $44M.
What does specialty diagnostics — research and development expenses mean?
Money spent on developing new products and improving existing ones in the Specialty Diagnostics segment.